The androgen receptor induces a distinct transcriptional program in castration resistant prostate cancer in man by Sharma, N, Massie, C, Ramos-Montoya, A, Scott, H, Stark, R, Warren, A, Mills, I, Neal, D

The androgen receptor induces a distinct transcriptional program in castration-resistant prostate cancer in man. by Sharma, N, Massie, C, Ramos-Montoya, A, Zecchini, V, Scott, H, Lamb, A, MacArthur, S, Stark, R, Warren, A, Mills, I, Neal, D

Towards derivation of a distinct signature permitting personalised treatment in prostate cancer by Lamb, A, Sharma, N, Russell, R, Ramos-Montoya, A, Ross-Adams, H, Whittaker, H, Shaw, G, Wadhwa, K, Hori, S, Warren, A, Neal, D

Towards derivation of a distinct signature permitting personalised treatment in prostate cancer by Lamb, A, Sharma, N, Russell, R, Ramos-Montoya, A, Whittaker, H, Ross-Adams, H, Shaw, G, Wadhwa, K, Hori, S, Warren, A, Neal, D

Independence of HIF1a and androgen signaling pathways in prostate cancer by Tran, MGB, Bibby, BAS, Yang, L, Lo, F, Warren, AY, Shukla, D, Osborne, M, Hadfield, J, Carroll, T, Stark, R, Scott, H, Ramos-Montoya, A, Massie, C, Maxwell, P, West, CML, Mills, IG, Neal, DE

Opportunities for quantitative translational modelling in oncology by Yates, JWT, Byrne, H, Chapman, SC, Chen, T, Cucurull-Sanchez, L, Delgado-SanMartin, J, di Veroli, G, Dovedi, SJ, Dunlop, C, Jena, R, Jodrell, D, Martin, E, Mercier, F, Ramos-Montoya, A, Struemper, H, Vicini, P

HES6 drives a critical AR transcriptional programme to induce castration‐resistant prostate cancer through activation of an E2F1‐mediated cell cycle network by Ramos-Montoya, A, Lamb, A, Russell, R, Carroll, T, Jurmeister, S, Galeano-Dalmau, N, Massie, C, Boren, J, Bon, H, Theodorou, V, Vias, M, Shaw, G, Sharma, N, Ross-Adams, H, Scott, H, Vowler, S, Howat, W, Warren, A, Wooster, R, Mills, I, Neal, D

The early effects of rapid androgen deprivation on human prostate cancer by Shaw, G, Whitaker, H, Corcoran, M, Dunning, M, Luxton, H, Kay, J, Massie, C, Miller, J, Lamb, A, Ross-Adams, H, Russell, R, Nelson, A, Eldridge, M, Lynch, A, Ramos-Montoya, A, Mills, I, Taylor, A, Arlt, W, Shah, N, Warren, A, Neal, D

Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study by Ross-Adams, H, Lamb, A, Dunning, M, Halim, S, Lindberg, J, Massie, C, Egevad, L, Russell, R, Ramos-Montoya, A, Vowler, S, Sharma, N, Kay, J, Whitaker, H, Clark, J, Hurst, R, Gnanapragasam, V, Shah, N, Warren, A, Cooper, C, Lynch, A, Stark, R, Mills, I, Grönberg, H, Neal, D

HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancer by Ross-Adams, H, Ball, S, Lawrenson, K, Halim, S, Russell, R, Wells, C, Strand, SH, Ørntoft, TF, Larson, M, Armasu, S, Massie, CE, Asim, M, Mortensen, MM, Borre, M, Woodfine, K, Warren, AY, Lamb, AD, Kay, J, Whitaker, H, Ramos-Montoya, A, Murrell, A, Sørensen, KD, Fridley, BL, Goode, EL, Gayther, SA, Masters, J, Neal, DE, Mills, IG